ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,987Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 199

$378K Total Retail Price of All Prescriptions

Rank: 89 out of 199

292 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 688 506 79 1 1
OMEPRAZOLE 425 295 56 2 4
SIMVASTATIN 298 206 44 3 2
AMLODIPINE BESYLATE 290 258 38 4 3
FUROSEMIDE 267 248 41 5 5
ATENOLOL 255 201 30 6 19
LISINOPRIL 253 220 39 7 6
POTASSIUM CHLORIDE 234 179 38 8 10
CITALOPRAM HBR 232 202 34 9 20
WARFARIN SODIUM 218 197 37 10 7
MELOXICAM 177 149 29 11 32
METOPROLOL SUCCINATE 171 154 23 12 11
LOSARTAN POTASSIUM 126 121* 16 13 15
ATORVASTATIN CALCIUM 123 100 24 14 8
SERTRALINE HCL 118 113* 18 15 23
GABAPENTIN 117 90 17 16 14
ALLOPURINOL 112 112 15 17 22
MONTELUKAST SODIUM 110 69 14 18 58
HYDROCHLOROTHIAZIDE 104 77 16 19 17
DIOVAN 101 85 13 20 42
METOPROLOL TARTRATE 97 97 14 21 12
ESCITALOPRAM OXALATE 90 46 11 22 36
CLOPIDOGREL 88 <11 <11 23 27
NEXIUM 87 76 11 24 46
PANTOPRAZOLE SODIUM 86 81* 16 25 25
GLIMEPIRIDE 82 70 11 26 38
SYNTHROID 81 <11 <11 27 41
ZOLPIDEM TARTRATE 81 76* 19 27 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 64 13 29 43
METFORMIN HCL ER 71 60 12 30 62
CLONIDINE HCL 71 <11 <11 30 52
CYMBALTA 68 56 13 32 44
ALENDRONATE SODIUM 67 <11 <11 33 29
CRESTOR 66 61* 11 34 31
DOXYCYCLINE HYCLATE 62 42 42 35 151
AMOXICILLIN 57 52* 43 36 118
RANITIDINE HCL 57 <11 <11 36 57
CARVEDILOL 56 56 11 38 21
OXYBUTYNIN CHLORIDE 55 <11 <11 39 97
METFORMIN HCL 54 <11 <11 40 13
KLOR-CON M10 54 <11 <11 40 99
NAMENDA 53 <11 <11 42 34
ALPRAZOLAM 53 <11 <11 B 42 24
VALSARTAN-HYDROCHLOROTHIAZIDE 53 <11 <11 42 83
LOSARTAN-HYDROCHLOROTHIAZIDE 53 <11 <11 42 49
PAROXETINE HCL 50 <11 <11 46 73
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.